Download Files:
CDK9-IN-13
$350 – $3,200
Products Details
Product Description
– CDK9-IN-13 (compound 38) is potent and selective CDK9 inhibitor, with an IC50 of <3 nM. CDK9-IN-13 exhibits short half-lives in rodents[1].
Web ID
– HY-139980
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C27H35N5O2
References
– [1]Barlaam B, et, al. Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement. J Med Chem. 2021 Oct 28;64(20):15189-15213.
CAS Number
– 2768712-71-4
Molecular Weight
– 461.60
Compound Purity
– 99.22
SMILES
– CC(C)N1C=C(C2=CC=NC3=C2C=C(C4CCN(CC(N5CCCCC5)=O)CC4)N3)C=CC1=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 2.5 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– CDK
Isoform
– CDK1;CDK12;CDK2;CDK7;CDK9
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
